| 摘要 |
<p>A pharmaceutical composition having excellent lipid-lowering potency and arteriosclerosis progression inhibiting effect. There is provided a pharmaceutical composition comprising a dihydronaphthylidine derivative being N-{1-butyl-4-[3-(3-hydroxypropoxy)phenyl]-2,2-dihydro-2-oxo-1,8-naphthylidin-3-yl}-N'-(2,6-diisopropyl-4-aminophenyl)urea or N-[1-butyl-4-[3-(3-pyridin-3-ylmethoxyphenyl)-2,2-dihydro-2-oxo-1,8-naphthylidin-3-yl]-N'-(2,6-diisopropylphenyl)urea, or its pharmacologically acceptable salt or pharmacologically acceptable prodrug, and an HMG-CoA reductase inhibitor.</p> |
